Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Arq. ciências saúde UNIPAR ; 27(3): 1388-1405, 2023.
Article in Portuguese | LILACS | ID: biblio-1426504

ABSTRACT

Introdução: Os materiais de origem humana geralmente são conservados em formaldeído, para possibilitar o estudo da anatomia humana, tal conservante possui baixo custo e boa fixação, contudo é toxico. Diante do exposto é necessário, o estudo de outros métodos de conservação, menos prejudiciais, como a solução de NaCl 30%. Objetivo: Comparar a conservação de peças anatômicas em solução de NaCl à 30% e formaldeído a 10%. Método: Pesquisa experimental, exploratória e descritiva, realizada com dois produtos de abortamento, no laboratório de anatomia de uma universidade pública, no estado do Paraná/BR. Foi realizada fixação em solução de formol 10%, em seguida uma amostra foi lavado em água corrente e armazenado em solução de NaCl à 30%. Após 6 meses da conservação em solução salina, foram coletadas amostras, estas foram submetidas a análise de crescimento bacteriano. Avaliou-se tonalidade e turgor cutâneo, odor e peso, bem como crescimento bacteriano. O estudo seguiu os preceitos éticos (CAAE: 53740121.9.0000.9247). Resultados: Foram realizadas observações após 24h, 7, 30, 60, 90 e 180 dias. O feto em solução de NaCl não possui odor, e diminuição do turgor da pele. Ambas a amostras não apresentaram crescimento bacteriano. Considerações finais: A solução de NaCl a 30% desidrata a pele, mas não altera significativamente a forma e estrutura, ainda não possui odor e nem toxicidade, o que garante benefícios a saúde de quem os manipula, bem como tal concentração de NaCl inibe de forma efetiva o crescimento bacteriano nos tecidos e na própria solução, se demostrando eficaz na conservação.


Introduction: The materials of human origin are usually preserved in formaldehyde, to enable the study of human anatomy, this preservative has low cost and good fixation, however it is toxic. Therefore, it is necessary to study other less harmful preservation methods, such as 30% NaCl solution. Objective: To compare the preservation of anatomical specimens in 30% NaCl solution and 10% formaldehyde solution. Method: Experimental, exploratory and descriptive research, carried out with two abortion products, in the anatomy laboratory of a public university, in the state of Paraná/BR. Fixation in 10% formaldehyde solution was performed, after which a sample was washed in running water and stored in a 30% NaCl solution. After 6 months of preservation in saline solution, samples were collected and submitted to bacterial growth analysis. Skin tone and turgor, odor, weight, and bacterial growth were evaluated. The study followed the ethical precepts (CAAE: 53740121.9.0000.9247). Results: Observations were made after 24h, 7, 30, 60, 90 and 180 days. The fetus in NaCl solution had no odor, and decreased skin turgor. Both samples showed no bacterial growth. Final considerations: The 30% NaCl solution dehydrates the skin, but does not alter significantly the shape and structure, and also has no odor or toxicity, which guarantees health benefits to those who handle them, and such concentration of NaCl inhibits effectively the bacterial growth in the tissues and in the solution itself, proving to be effective in conservation.


Introducción: Los materiales de origen humano suelen conservarse en formol, para posibilitar el estudio de la anatomía humana, este conservante tiene bajo coste y buena fijación, sin embargo es tóxico. Por ello, es necesario estudiar otros métodos de conservación menos nocivos, como la solución de NaCl al 30%. Objetivo: Comparar la conservación de especímenes anatómicos en solución de NaCl al 30% y en solución de formaldehído al 10%. Método: Investigación experimental, exploratoria y descriptiva, realizada con dos abortos, en el laboratorio de anatomía de una universidad pública, en el estado de Paraná/BR. Fue realizada fijación en solución de formaldehído al 10%, después de lo cual la muestra fue lavada en agua corriente y almacenada en solución de NaCl al 30%. Tras 6 meses de conservación en solución salina, se recogieron las muestras y se sometieron a análisis de crecimiento bacteriano. Se evaluaron el tono y la turgencia de la piel, el olor, el peso y el crecimiento bacteriano. El estudio siguió los preceptos éticos (CAAE: 53740121.9.0000.9247). Resultados: Las observaciones se realizaron después de 24h, 7, 30, 60, 90 y 180 días. El feto en solución de NaCl no tenía olor, y la turgencia de la piel disminuyó. Ambas muestras no mostraron crecimiento bacteriano. Consideraciones finales: La solución de NaCl al 30% deshidrata la piel, pero no altera significativamente la forma y estructura, además no tiene olor ni toxicidad, lo que garantiza beneficios para la salud de quienes los manipulan, y dicha concentración de NaCl inhibe eficazmente el crecimiento bacteriano en los tejidos y en la propia solución, demostrando ser eficaz en la conservación.


Subject(s)
Humans , Preservatives, Pharmaceutical/chemistry , Sodium Chloride/chemistry , Fertilization/drug effects , Anatomy , Bacterial Growth , Human Body
2.
J Appl Toxicol ; 41(10): 1687-1699, 2021 10.
Article in English | MEDLINE | ID: mdl-33624850

ABSTRACT

The safety assessment of cosmetic products is based on the safety of the ingredients, which requires information on chemical structures, toxicological profiles, and exposure data. Approximately 6% of the population is sensitized to cosmetic ingredients, especially preservatives and fragrances. In this context, the aim of this study was to perform a hazard assessment and risk characterization of benzalkonium chloride (BAC), benzyl alcohol (BA), caprylyl glycol (CG), ethylhexylglycerin (EG), chlorphenesin (CP), dehydroacetic acid (DHA), sodium dehydroacetate (SDH), iodopropynyl butylcarbamate (IPBC), methylchloroisothiazolinone and methylisothiazolinone (MCI/MIT), methylisothiazolinone (MIT), phenoxyethanol (PE), potassium sorbate (PS), and sodium benzoate (SB). Considering the integrated approaches to testing and assessment (IATA) and weight of evidence (WoE) as a decision tree, based on published safety reports. The hazard assessment was composed of a toxicological matrix correlating the toxicity level, defined as low (L), moderate (M), or high (H) and local or systemic exposure, considering the endpoints of skin sensitization, skin irritation, eye irritation, phototoxicity, acute oral toxicity, carcinogenicity, mutagenicity/genotoxicity, and endocrine activity. In a risk assessment approach, most preservatives had a margin of safety (MoS) above 100, except for DHA, SDH, and EG, considering the worst-case scenario (100% dermal absorption). However, isolated data do not set up a safety assessment. It is necessary to carry out a rational risk characterization considering hazard and exposure assessment to estimate the level of risk of an adverse health outcome, based on the concentration in a product, frequency of use, type of product, route of exposure, body surface location, and target population.


Subject(s)
Cosmetics/chemistry , Cosmetics/toxicity , Preservatives, Pharmaceutical/chemistry , Preservatives, Pharmaceutical/toxicity , Risk Assessment/methods , Toxicity Tests/methods , Consumer Product Safety , Dermatitis/diagnosis , Dermatitis, Phototoxic/diagnosis , Eye Diseases/diagnosis , Humans
3.
Daru ; 28(2): 635-646, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32856238

ABSTRACT

BACKGROUND: The purpose of the present study was to investigate the antioxidant and antimicrobial activities of a conventional preservative system containing desferrioxamine mesylate (DFO) and optimize the composition of the system through mathematical models. METHODS: Different combinations of ethylenediaminetetraacetic acid (EDTA), sodium metabisulfite (SM), DFO and methylparaben (MP) were prepared using factorial design of experiments. The systems were added to ascorbic acid (AA) solution and the AA content over time, at room temperature and at 40 °C was determined by volumetric assay. The systems were also evaluated for antioxidant activity by a fluorescence-based assay. Antimicrobial activity was assessed by microdilution technique and photometric detection against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans and Aspergillus brasiliensis. A multi-criteria decision approach was adopted to optimize all responses by desirability functions. RESULTS: DFO did not extend the stability of AA over time, but displayed a better ability than EDTA to block the pro-oxidant activity of iron. DFO had a positive interaction with MP in microbial growth inhibition. The mathematical models showed adequate capacity to predict the responses. Statistical optimization aiming to meet the quality specifications of the ascorbic acid solution indicated that the presence of DFO in the composition allows to decrease the concentrations of EDTA, SM and MP. CONCLUSION: DFO was much more effective than EDTA in preventing iron-catalyzed oxidation. In addition, DFO improved the inhibitory response of most microorganisms tested. The Quality by Design concepts aided in predicting an optimized preservative system with reduced levels of conventional antioxidants and preservatives, suggesting DFO as a candidate for multifunctional excipient.


Subject(s)
Anti-Infective Agents/pharmacology , Antioxidants/pharmacology , Ascorbic Acid/pharmacology , Deferoxamine/chemistry , Preservatives, Pharmaceutical/chemistry , Anti-Infective Agents/chemistry , Antioxidants/chemistry , Ascorbic Acid/chemistry , Aspergillus/drug effects , Candida albicans/drug effects , Edetic Acid/chemistry , Escherichia coli/drug effects , Microbial Sensitivity Tests , Models, Theoretical , Parabens/chemistry , Pseudomonas aeruginosa/drug effects , Staphylococcus aureus/drug effects , Sulfites/chemistry
4.
An Bras Dermatol ; 95(2): 194-199, 2020.
Article in English | MEDLINE | ID: mdl-32156503

ABSTRACT

BACKGROUND: Kathon CG, a combination of methylchloroisothiazolinone and methylisothiazolinone, is widely used as preservative in cosmetics, as well in household cleaning products, industrial products such as paints and glues. It has emerged as an important sensitizing agent in allergic contact dermatitis. OBJECTIVES: This study evaluated the reactivity to this substance in patients subjected to patch tests at the Dermatology Institute in Bauru, São Paulo from 2015 to 2017 and its correlation with other preservatives, the professional activity and location of the lesions. METHODS: The patients were submitted to standard series of epicutaneous tests, standardized by the Brazilian Group Studies on Contact Dermatitis. RESULTS: Out the 267 patients tested, 192 presented positivity to at least one substance and 29 of the patients (15.10%) presented reaction to Kathon CG, with predominance of the female gender (n=27); main professional activity associated with Kathon CG sensibilization was cleaning (17.24%), followed by aesthetic areas (13.79%) and health care (10.34%). The most prevalent sensitizations among the substances tested were nickel sulphate (56.3%), followed by cobalt chloride (23.4%), neomycin (18.2%), potassium dichromate (17.7%), thimerosal (14.5%), formaldehyde (13.2%), paraphenylenediamine (9.3%), and fragrance mix (8.3%). STUDY LIMITATIONS: We do not have data from patients that were submitted to patch test a decade ago in order to confront to current data and establish whether or no sensitization to Kathon CG has increased. CONCLUSION: High positivity to Kathon CG corroborates the recent findings in the literature, suggesting more attention to concentration of this substance, used in cosmetics and products for domestic use.


Subject(s)
Dermatitis, Allergic Contact/diagnosis , Patch Tests/methods , Thiazoles/analysis , Adult , Brazil , Cosmetics/adverse effects , Cosmetics/chemistry , Dermatitis, Allergic Contact/etiology , Female , Humans , Logistic Models , Male , Middle Aged , Patch Tests/statistics & numerical data , Preservatives, Pharmaceutical/adverse effects , Preservatives, Pharmaceutical/chemistry , Retrospective Studies , Statistics, Nonparametric , Thiazoles/adverse effects
5.
An. bras. dermatol ; An. bras. dermatol;95(2): 194-199, Mar.-Apr. 2020. tab, graf
Article in English | LILACS, Coleciona SUS | ID: biblio-1130847

ABSTRACT

Abstract Background: Kathon CG, a combination of methylchloroisothiazolinone and methylisothiazolinone, is widely used as preservative in cosmetics, as well in household cleaning products, industrial products such as paints and glues. It has emerged as an important sensitizing agent in allergic contact dermatitis. Objectives: This study evaluated the reactivity to this substance in patients subjected to patch tests at the Dermatology Institute in Bauru, São Paulo from 2015 to 2017 and its correlation with other preservatives, the professional activity and location of the lesions. Methods: The patients were submitted to standard series of epicutaneous tests, standardized by the Brazilian Group Studies on Contact Dermatitis. Results: Out the 267 patients tested, 192 presented positivity to at least one substance and 29 of the patients (15.10%) presented reaction to Kathon CG, with predominance of the female gender (n = 27); main professional activity associated with Kathon CG sensibilization was cleaning (17.24%), followed by aesthetic areas (13.79%) and health care (10.34%). The most prevalent sensitizations among the substances tested were nickel sulphate (56.3%), followed by cobalt chloride (23.4%), neomycin (18.2%), potassium dichromate (17.7%), thimerosal (14.5%), formaldehyde (13.2%), paraphenylenediamine (9.3%), and fragrance mix (8.3%). Study limitations: We do not have data from patients that were submitted to patch test a decade ago in order to confront to current data and establish whether or no sensitization to Kathon CG has increased. Conclusion: High positivity to Kathon CG corroborates the recent findings in the literature, suggesting more attention to concentration of this substance, used in cosmetics and products for domestic use.


Subject(s)
Thiazoles/analysis , Patch Tests/methods , Dermatitis, Allergic Contact/diagnosis , Preservatives, Pharmaceutical/adverse effects , Preservatives, Pharmaceutical/chemistry , Thiazoles/adverse effects , Brazil , Patch Tests/statistics & numerical data , Logistic Models , Retrospective Studies , Dermatitis, Allergic Contact/etiology , Statistics, Nonparametric , Cosmetics/adverse effects , Cosmetics/chemistry , Middle Aged
6.
Molecules ; 24(3)2019 Jan 28.
Article in English | MEDLINE | ID: mdl-30696032

ABSTRACT

Betanin is the only betalain approved for use in food and pharmaceutical products as a natural red colorant. However, the antioxidant power and health-promoting properties of this pigment have been disregarded, perhaps due to the difficulty in obtaining a stable chemical compound, which impairs its absorption and metabolism evaluation. Herein, betanin was purified by semi-preparative HPLC-LC/MS and identified by LC-ESI(+)-MS/MS as the pseudomolecular ion m/z 551.16. Betanin showed significant stability up to -30 °C and mild stability at chilling temperature. The stability and antioxidant ability of this compound were assessed during a human digestion simulation and ex vivo colon fermentation. Half of the betanin amount was recovered in the small intestine digestive fluid and no traces were found after colon fermentation. Betanin high antioxidant ability was retained even after simulated small intestine digestion. Betanin, besides displaying an inherent colorant capacity, was equally effective as a natural antioxidant displaying peroxy-radical scavenger ability in pork meat. Betanin should be considered a multi-functional molecule able to confer an attractive color to frozen or refrigerated foods, but with the capacity to avoid lipid oxidation, thereby preserving food quality. Long-term supplementation by beetroot, a rich source of betanin, should be stimulated to protect organisms against oxidative stress.


Subject(s)
Betacyanins/chemistry , Food Additives/chemistry , Antioxidants/chemistry , Antioxidants/pharmacology , Betacyanins/isolation & purification , Betacyanins/pharmacology , Biological Availability , Chromatography, High Pressure Liquid , Drug Stability , Food Additives/isolation & purification , Food Additives/pharmacology , Gastrointestinal Absorption , Humans , Lipid Peroxidation/drug effects , Preservatives, Pharmaceutical/chemistry , Preservatives, Pharmaceutical/pharmacology , Spectrometry, Mass, Electrospray Ionization , Tandem Mass Spectrometry
7.
J Appl Microbiol ; 122(4): 900-910, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28055127

ABSTRACT

AIMS: The aim of this work was to evaluate the efficacy and safety of Lippia origanoides essential oil as a preservative in industrial products. METHODS AND RESULTS: The composition, antimicrobial activity, mutagenic and toxic potential of L. origanoides were determined. Then, the effect of essential oil as a preservative in food, cosmetics and pharmaceutical products was evaluated. The essential oil of L. origanoides consisted mainly of oxygenated monoterpenes (38·13%); 26·28% corresponded to the compound carvacrol. At concentrations ranging from 0·312 to 1·25 µl ml-1 and in association with polysorbate 80, the essential oil of L. origanoides inhibited the growth of all the tested micro-organisms. The medium lethal dose in mice was 3·5 g kg-1 , which categorizes it as nontoxic according to the European Union criteria, and negative results in the Ames test indicated that this oil was not mutagenic. In combination with polysorbate 80, the essential oil exerted preservative action on orange juice, cosmetic and pharmaceutical compositions, especially in the case of aqueous-based products. CONCLUSIONS: Lippia origanoides essential oil is an effective and safe preservative for orange juice, pharmaceutical and cosmetic products. SIGNIFICANCE AND IMPACT OF THE STUDY: This study allowed for the complete understanding of the antimicrobial action and toxicological potential of L. origanoides essential oil. These results facilitate the development of a preservative system based on L. origanoides essential oil.


Subject(s)
Cosmetics , Food Preservatives/pharmacology , Lippia/chemistry , Oils, Volatile/pharmacology , Preservatives, Pharmaceutical/pharmacology , Animals , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Cymenes , Food Preservatives/chemistry , Food Preservatives/toxicity , Mice , Monoterpenes/chemistry , Oils, Volatile/chemistry , Oils, Volatile/toxicity , Pharmaceutic Aids/chemistry , Pharmaceutic Aids/pharmacology , Pharmaceutic Aids/toxicity , Plant Oils/chemistry , Plant Oils/pharmacology , Plant Oils/toxicity , Preservatives, Pharmaceutical/chemistry , Preservatives, Pharmaceutical/toxicity
8.
Medwave ; 14(2): e5923, 2014 Mar 26.
Article in English, Spanish | MEDLINE | ID: mdl-25197986

ABSTRACT

Chilean legislators have voted to ban vaccines preserved with thiomersal, an initiative that the Executive has vetoed. Most scientific evidence has dismissed the alleged toxicity of this substance, in accordance with the formal and publicly expressed opinion of local experts, and yet, medical authorities have issued contradictory statements. Some have argued that the principle of precaution suggests eliminating thiomersal preserved vaccines; others have declared that current vaccines should be maintained to protect the population. From the perspective of bioethics, this polemic is another example of the shortcoming of the deliberation process leading to controversial laws in lieu of including citizens in the discussion of regulations that harbor uncertainties, and respect for individual autonomy to accept or reject public immunization programs. The Chilean legal system has been unwilling to implement participatory democratic procedures like plebiscites or institutions such as the ombudsman. In 2006 a law was enacted that creates a National Commission of Bioethics, but successive governments have failed to create such a commission, which is an efficient social instrument to conduct deliberation on bioethical issues that require a balanced participation of the public, experts, and politicians.


El Poder Legislativo chileno propone una ley que elimine el timerosal como preservante de las vacunas parenterales del Programa Nacional de Inmunizaciones, proyecto que el Poder Ejecutivo se ha propuesto vetar. El mundo científico informa mayoritariamente que la sospecha de neurotoxicidad atribuida al timerosal es infundada. Pese a ello, las autoridades médicas han oscilado entre sostener que la precaución sugiere apoyar la ley y en otros momentos han manifestando que es más precautorio mantener los programas de vacunación actualmente vigentes. Estas contradicciones y oposiciones ilustran que materias que conciernen a la ciudadanía, requieren una reflexión bioética acabada sobre las políticas públicas sanitarias. Han quedado claro las deficiencias de la deliberación política y la falta de participación social en decisiones que, dado el grado de incertidumbre involucrada en temas como inmunización, requieren no sólo la inclusión de la ciudadanía sino el respeto de la autonomía individual para aceptar o rechazar la inclusión en los programas de vacunación propuestos por las políticas sanitarias. La participación ciudadana en nuestro país se ve severamente limitada por la falta de instrumentos sociales como el plebiscito, el ombudsman y, especialmente, la desidia en crear la Comisión Nacional de Bioética exigida por la Ley 20.120 de 2006, una de cuyas funciones más importantes es mediar deliberativamente entre legos, expertos y políticos en la generación de políticas sanitarias legitimadas por la participación ciudadana.


Subject(s)
Legislation, Drug , Preservatives, Pharmaceutical/adverse effects , Thimerosal/adverse effects , Vaccines/adverse effects , Bioethical Issues , Chile , Humans , Preservatives, Pharmaceutical/chemistry , Thimerosal/chemistry , Vaccines/administration & dosage , Vaccines/chemistry
9.
Medwave ; 14(2): e5929, 2014 Mar 31.
Article in English, Spanish | MEDLINE | ID: mdl-25198357

ABSTRACT

This article analyzes the recent controversy regarding the introduction of a bill to Chilean Congress that aims to ban thiomersal and/or any trace of organomercurial compounds from vaccines in the country. Rather than providing a formal overview of all available evidence, this analysis focuses on the reasons behind the controversy, the scientific evidence invoked by both sides in the debate, and the anomalies in the healthcare decision-making process.


El presente artículo tiene por objetivo analizar la controversia ocurrida en Chile, especialmente durante los últimos meses, en relación a un proyecto de ley que busca prohibir la fabricación, importación, comercialización o distribución de vacunas que contengan dentro de sus compuestos, en cualquier nivel de concentración, timerosal o compuestos organomercúricos. Sin constituir una síntesis formal de toda la investigación existente, se analiza la evidencia científica que los distintos actores han utilizado, las razones de la controversia y las anomalías en el proceso de toma de decisión sanitaria.


Subject(s)
Legislation, Drug , Preservatives, Pharmaceutical/adverse effects , Thimerosal/adverse effects , Vaccines/adverse effects , Chile , Decision Making , Humans , Preservatives, Pharmaceutical/chemistry , Thimerosal/chemistry , Vaccines/administration & dosage , Vaccines/chemistry
10.
Diagn Microbiol Infect Dis ; 76(4): 470-6, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23726649

ABSTRACT

The control of canine visceral leishmaniasis (CVL) is imperative, but euthanasia of seropositive dogs has been highly criticized. Commonly used, immunodiagnostic tests, including Dual-Path Platform®, enzyme-linked immunosorbent assay, and immunofluorescent antibody test, have failed at detecting asymptomatic dogs in endemic areas. In this context, new serological methods are needed. Flow cytometry serology has demonstrated potential as a test with excellent performance for CVL. In this study, we proposed to establish the best conditions for preserving Leishmania infantum promastigote antigens employed in this serology test. During 12 months of follow-up, promastigotes were maintained in different preservatives (phosphate-buffered saline with 3% fetal bovine serum, phenol 0.35%, thimerosal 0.01%, and formaldehyde 0.5%) and stored at 3 distinct temperatures (25 °C, 4 °C, and -20 °C). During the study period, the morphological characteristics of the promastigotes were assessed by flow cytometry according to the forward and side scatter parameters and also under optical microscopic analysis. Reactivity performance was evaluated as the percentage of positive fluorescent parasites in the sera of naturally infected and noninfected dogs. Microbiological analysis was performed at 2 time points, the first and sixth months, to rule out contamination of stored promastigotes. Taken together, our results indicated that the best conditions to preserve fixed L. infantum antigens were storage in formaldehyde at 4 °C. Promastigotes presented the best morphological profile, with appropriate antigenic stability even at 4 °C, in an inexpensive preservative for a long period of conservation.


Subject(s)
Antigens, Protozoan/analysis , Dog Diseases/diagnosis , Leishmania infantum/isolation & purification , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/veterinary , Animals , Antibodies, Protozoan/chemistry , Antibodies, Protozoan/immunology , Antigens, Protozoan/chemistry , Antigens, Protozoan/immunology , Dog Diseases/blood , Dog Diseases/immunology , Dog Diseases/parasitology , Dogs , Flow Cytometry/veterinary , Fluorescent Antibody Technique, Indirect , Formaldehyde/chemistry , Immunoglobulin G/chemistry , Immunoglobulin G/immunology , Leishmania infantum/immunology , Leishmaniasis, Visceral/blood , Leishmaniasis, Visceral/immunology , Life Cycle Stages , Preservatives, Pharmaceutical/chemistry , Protein Stability , Temperature
11.
Anesth Analg ; 114(2): 450-5, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22167772

ABSTRACT

BACKGROUND: The N-methyl-d-aspartate receptor antagonist ketamine and its active enantiomer, S(+)-ketamine, have been injected in the epidural and subarachnoid spaces to treat acute postoperative pain and relieve neuropathic pain syndrome. In this study we evaluated the effects of a single dose of preservative-free S(+)-ketamine, in doses usually used in clinical practice, in the spinal cord and meninges of dogs. METHODS: Under anesthesia (IV etomidate (2 mg/kg) and fentanyl (0.005 mg/kg), 16 dogs (6 to 15 kg) were randomized to receive a lumbar intrathecal injection (L5/6) of saline solution of 0.9% (control group) or S(+)-ketamine 1 mg/kg(-1) (ketamine group). All doses were administered in a volume of 1 mL over a 10-second interval. Accordingly, injection solution ranged from 0.6% to 1.5%. After 21 days of clinical observation, the animals were killed; spinal cord, cauda equina root, and meninges were removed for histological examination with light microscopy. Tissues were examined for demyelination (Masson trichrome), neuronal death (hematoxylin and eosin) and astrocyte activation (glial fibrillary acidic protein). RESULTS: No clinical or histological alterations of spinal tissue or meninges were found in animals from either control or ketamine groups. CONCLUSION: A single intrathecal injection of preservative-free S(+)-ketamine, at 1 mg/kg(-1) dosage, over a concentration range of 6 to 15 mg/mL injected in the subarachnoid space in a single puncture, did not produce histological alterations in this experimental model.


Subject(s)
Analgesics/administration & dosage , Excitatory Amino Acid Antagonists/administration & dosage , Ketamine/administration & dosage , Meninges/drug effects , Preservatives, Pharmaceutical/chemistry , Spinal Cord/drug effects , Analgesics/chemistry , Animals , Cell Death/drug effects , Chemistry, Pharmaceutical , Dogs , Excitatory Amino Acid Antagonists/chemistry , Female , Glial Fibrillary Acidic Protein/metabolism , Injections, Spinal , Ketamine/chemistry , Male , Meninges/metabolism , Meninges/pathology , Myelin Sheath/metabolism , Random Allocation , Spinal Cord/metabolism , Spinal Cord/pathology , Time Factors
12.
AAPS PharmSciTech ; 12(2): 732-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21643865

ABSTRACT

Even though the synthetic preservatives may offer a high antimicrobial efficacy, they are commonly related to adverse reactions and regarded as having potentially harmful effects caused by chronic consumption. The development of natural preservatives provides a way of reducing the amount of synthetic preservatives normally used in pharmaceutical and cosmetic preparations. In addition, these agents have less toxic effects and represent a possible natural and safer alternative of the preservatives. The purpose of this research was to evaluate the Rubus rosaefolius Smith extract efficiency as a natural preservative in base formulations. Of the extract, 0.2% (w/w) was assayed for its effectiveness of antimicrobial protection in two different base formulations (emulsion and gel). The microbial challenge test was performed following the standard procedures proposed by The United States Pharmacopoeia 33nd, European Pharmacopoeia 6th, Japanese Pharmacopoeia 15th, and the Cosmetics, Toiletries, and Fragrance Association using standardized microorganisms. The results demonstrated that R. rosaefolius extract at the studied concentration reduced the bacterial inocula, satisfying the criterion in all formulations, even though it was not able to present an effective preservative behavior against fungi. Thus, the investigation of new natural substances with preservative properties that could be applied in pharmaceutical and cosmetic products is relevant due to the possibility of substituting or decreasing the concentration of synthetic preservatives, providing a way for the development of safer formulas for the use of consumers.


Subject(s)
Biological Products/chemistry , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Preservatives, Pharmaceutical/chemistry , Rosaceae , Administration, Topical , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/chemistry , Anti-Infective Agents/isolation & purification , Biological Products/administration & dosage , Biological Products/isolation & purification , Chemistry, Pharmaceutical , Cosmetics/administration & dosage , Cosmetics/chemistry , Cosmetics/isolation & purification , Escherichia coli/drug effects , Escherichia coli/growth & development , Microbial Sensitivity Tests/methods , Pharmacopoeias as Topic , Plant Extracts/administration & dosage , Plant Leaves/chemistry , Preservatives, Pharmaceutical/administration & dosage , Preservatives, Pharmaceutical/isolation & purification , United States
13.
J Comput Aided Mol Des ; 21(9): 527-38, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17960329

ABSTRACT

A discriminant function based on topological descriptors was derived from a training set composed by anticonvulsants of clinical use or in clinical phase of development and compounds with other therapeutic uses. This model was internally and externally validated and applied in the virtual screening of chemical compounds from the Merck Index 13th. Methylparaben (Nipagin), a preservative widely used in food, cosmetics and pharmaceutics, was signaled as active by the discriminant function and tested in mice in the Maximal Electroshock (MES) test (i.p. administration), according to the NIH Program for Anticonvulsant Drug Development. Based on the results of Methylparaben, Propylparaben (Nipasol), another preservative usually used in association with the former, was also tested. Both methyl and propylparaben were found active in mice at doses of 30, 100, and 300 mg/kg. The discovery of the anticonvulsant activities in the MES test of methylparaben and propylparaben might be useful for the development of new anticonvulsant medications, specially considering the well-known toxicological profile of these drugs.


Subject(s)
Anticonvulsants/pharmacology , Chemistry, Pharmaceutical/statistics & numerical data , Databases, Factual , Parabens/pharmacology , Preservatives, Pharmaceutical/pharmacology , Animals , Anticonvulsants/chemistry , Computer Simulation , Drug Evaluation, Preclinical , Electroshock , Food Preservatives/chemistry , Food Preservatives/pharmacology , Mice , Molecular Structure , Parabens/chemistry , Preservatives, Pharmaceutical/chemistry , Quantitative Structure-Activity Relationship , Seizures/drug therapy , Seizures/etiology
14.
Am J Perinatol ; 24(7): 387-400, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17564957

ABSTRACT

Breastfeeding is the best natural protection infants have against morbidity and mortality, and the development of safe and effective vaccines has made it possible to immunize children against infectious disease. Both of these mechanisms for ensuring good health in children may be compromised by contact with mercury (Hg). Maternal exposure to environmental Hg during pregnancy can predispose nursing children to neurodevelopmental disorders. Despite the World Health Organization assurance that thimerosal-preserved vaccines are safe to use in infants, the United States, the European Union, and dozens of other countries have eliminated thimerosal as a vaccine preservative and stopped the immunization of children with such vaccines. Because of the increase in environmental pollution and the need to produce cheap and safe vaccines, there is a need to address the uncertainty of vaccine-ethylmercury risk of toxicity and Hg exposure during breastfeeding.


Subject(s)
Breast Feeding , Maternal Exposure , Mercury/analysis , Milk, Human/chemistry , Vaccines/analysis , Central Nervous System/growth & development , Dose-Response Relationship, Drug , Ethylmercury Compounds/chemistry , Female , Humans , Infant , Infant, Newborn , Infant, Premature , Mercury/metabolism , Preservatives, Pharmaceutical/chemistry , Risk Factors , Thimerosal/chemistry
15.
Regul Toxicol Pharmacol ; 49(1): 17-24, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17566620

ABSTRACT

Children are exposed to Hg from mothers (via placenta and lactation), environment (food), and in many parts of the world by thimerosal-containing vaccines (TCV) during immunization. Neurodevelopment studies based on infant hair-Hg (HHg) have been designed without explicit attention to the factors associated with changes in infant physiology and Hg sources of exposure. A longitudinal study of changes in HHg concentrations from birth to 5 years was done in a sample of children from Porto Velho (Rondonia), Brazilian Amazonia. The study extracted information from the asymmetry associated with maternal and infant HHg changes at specified sampling: birth (fetal exposure), 6 months of exclusive breastfeeding, 36 months (weaning) and 60 months (pre-school). The distribution of HHg in breastfed infants followed a pattern different from their mothers. While mothers had the highest HHg concentrations at childbirth, infants showed the highest HHg values at 6 months after the recommended full schedule (six shots) of immunization with TCV; after that, the downward trend in HHg shown by children coincided with both weaning and less frequent vaccination period (5 years). Extended lactation (up to 36 months) was not significantly associated with HHg of infants or mothers; however, significant association (Spearman's r) between maternal and infant HHg concentration was seen at birth (r=0.3534; P=0.001), 6 months (r=0.4793; P<0.0001), 3 years (r=0.0122; P=0.012) and 5 years (r=0.0357; P=0.005). Maternal postpartum metabolic changes, infant development and transitional diets and possibly Hg from TCV contribute to the asymmetry of HHg changes between mothers and children.


Subject(s)
Environmental Exposure/analysis , Hair/chemistry , Mercury/analysis , Prenatal Exposure Delayed Effects , Preservatives, Pharmaceutical/pharmacokinetics , Thimerosal/pharmacokinetics , Adolescent , Adult , Brazil , Child , Child, Preschool , Environmental Monitoring , Female , Humans , Infant , Infant, Newborn , Maternal Exposure , Mercury/blood , Middle Aged , Pregnancy , Prenatal Exposure Delayed Effects/metabolism , Preservatives, Pharmaceutical/chemistry , Thimerosal/chemistry
16.
Acta Trop ; 98(1): 87-93, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16527224

ABSTRACT

Montenegro skin test (MST) represents the main complementary diagnostic test for tegumentary leishmaniases (TL) in endemic regions. Most antigen formulations used for the MST contain thimerosal as preservative. The Food and Drug Administration (FDA), however, recommended reducing or eliminating thimerosal from vaccines and other biological reagents and the Agência Nacional de Vigilância Sanitária (ANVISA) in Brazil, prohibited the use of mercurial compounds in immunobiologicals. In the search for an alternative stabilizer, phenol and thimerosal were tested as antigen preservatives in MST. Formulations were tested when fresh and after a 12-month storage at 4 degrees C in TL confirmed mice and human patients, and were evaluated for protein constitution by SDS-PAGE, Western blot and anti-gp63 ELISA. In mice, a decrease in the diagnostic effectiveness in merthiolate formulation was observed after a 12-month storage. SDS-PAGE, Western blot and anti-gp63 ELISA analyses showed a degradation of antigen proteins in both formulations after 12-month storage and that phenol-preserved antigen was quantitatively and qualitatively better than the merthiolate-preserved one. In patients, the average of induration diameter was larger in fresh antigens (p<0.05). However, storage time did not jeopardize their diagnostic capacity. No non-specific reactions produced by phenol or merthiolate were observed neither in humans nor in mice. Phenol could be a good alternative to replace the merthiolate in MST, and despite the proteolytic activity, antigens remain viable for at least 12 months.


Subject(s)
Antigens, Protozoan/chemistry , Antigens, Protozoan/immunology , Leishmaniasis, Cutaneous/diagnosis , Phenol/chemistry , Preservatives, Pharmaceutical/chemistry , Skin Tests/methods , Thimerosal/chemistry , Animals , Drug Storage , Female , Humans , Leishmaniasis, Cutaneous/immunology , Mice , Phenol/pharmacology , Preservatives, Pharmaceutical/pharmacology , Thimerosal/pharmacology
17.
Int J Pharm ; 273(1-2): 1-8, 2004 Apr 01.
Article in English | MEDLINE | ID: mdl-15010124

ABSTRACT

Microspheres of polymers like poly(lactic-co-glycolic acid) (PLGA) have been studied as a vehicle for controlled release vaccines. They require materials and processes that might change the protein antigenicity. Lactic acid is produced during microsphere degradation that occurs in tandem with protein liberation. In addition, most of the proteins that have been used in microencapsulation studies contain Thimerosal((R))(TM) and this can introduce another undesirable effect for their stability. We demonstrated in vitro that the thiosalycilic acid (TSA), produced after the reduction of TM by lactic acid, reduces the S-S bridge of the previously incubated diphtheric toxoid (Dtxd). This reduction is immediately followed by blocking the two -SH formed by the same TSA molecules. In the light of these conclusions it is necessary now, to reinterpret the in vitro protein degradation-stabilization data in the presence of PLGA microspheres, mainly for those proteins which contain S-S. We propose that all the PLGA microspheres microencapsulation studies and protein structural considerations should be done in the absence of TM as preservative.


Subject(s)
Diphtheria Toxoid/chemistry , Lactic Acid/chemistry , Polyglycolic Acid/chemistry , Polymers/chemistry , Preservatives, Pharmaceutical/chemistry , Thimerosal/chemistry , Drug Carriers/chemistry , Drug Interactions , Drug Stability , Microspheres , Polylactic Acid-Polyglycolic Acid Copolymer
18.
J Endod ; 30(1): 42-4, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14760907

ABSTRACT

The purpose of this study was to determine if citric-acid solutions for endodontic use can become contaminated and if the addition of a microbiological stabilizer to the acid would modify this situation. Five types of microorganisms were inoculated in tubes containing 10% citric-acid solutions, pH 1.8 (group A1), and 10% solution, pH 1.8, combined with 0.1% sodium benzoate (group A2). The results demonstrated that solutions of group A1 were contaminated with Candida albicans in 100% of the tubes, Escherichia coli in 80%, and Enterococcus faecalis in 50%. When stabilizer was added (group A2), C. albicans grew in only 30% of tubes and all bacterial species were neutralized.


Subject(s)
Anti-Infective Agents/pharmacology , Citric Acid/pharmacology , Drug Contamination/prevention & control , Preservatives, Pharmaceutical/pharmacology , Root Canal Irrigants/pharmacology , Sodium Benzoate/pharmacology , Anti-Infective Agents/chemistry , Bacillus subtilis/drug effects , Bacillus subtilis/growth & development , Candida albicans/drug effects , Candida albicans/growth & development , Citric Acid/chemistry , Colony Count, Microbial , Enterococcus faecalis/drug effects , Enterococcus faecalis/growth & development , Escherichia coli/drug effects , Escherichia coli/growth & development , Humans , Hydrogen-Ion Concentration , Preservatives, Pharmaceutical/chemistry , Root Canal Irrigants/chemistry , Sodium Benzoate/chemistry , Streptococcus mutans/drug effects , Streptococcus mutans/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL